These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25706312)

  • 41. Optogenetics-Mediated Gene Therapy for Retinal Diseases.
    Tomita H; Sugano E
    Adv Exp Med Biol; 2021; 1293():535-543. PubMed ID: 33398840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optogenetics for visual restoration: From proof of principle to translational challenges.
    Lindner M; Gilhooley MJ; Hughes S; Hankins MW
    Prog Retin Eye Res; 2022 Nov; 91():101089. PubMed ID: 35691861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases.
    Wiley LA; Burnight ER; Songstad AE; Drack AV; Mullins RF; Stone EM; Tucker BA
    Prog Retin Eye Res; 2015 Jan; 44():15-35. PubMed ID: 25448922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-syndromic retinal ciliopathies: translating gene discovery into therapy.
    Estrada-Cuzcano A; Roepman R; Cremers FP; den Hollander AI; Mans DA
    Hum Mol Genet; 2012 Oct; 21(R1):R111-24. PubMed ID: 22843501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Artificial vision.
    Humayun MS; de Juan E
    Eye (Lond); 1998; 12 ( Pt 3b)():605-7. PubMed ID: 9775223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospects of Optogenetic Prosthesis of the Degenerative Retina of the Eye.
    Ostrovsky MA; Kirpichnikov MP
    Biochemistry (Mosc); 2019 May; 84(5):479-490. PubMed ID: 31234763
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human umbilical tissue-derived cells rescue retinal pigment epithelium dysfunction in retinal degeneration.
    Cao J; Murat C; An W; Yao X; Lee J; Santulli-Marotto S; Harris IR; Inana G
    Stem Cells; 2016 Feb; 34(2):367-79. PubMed ID: 26523756
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases.
    Kaur G; Singh NK
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vision restoration: science fiction or reality?].
    Picaud S; Sahel JA
    Med Sci (Paris); 2020 Nov; 36(11):1038-1044. PubMed ID: 33151850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-based therapies for retinal degenerative diseases: a thousand strategies.
    Lewallen M; Xie T
    J Glaucoma; 2013; 22 Suppl 5():S42-5. PubMed ID: 23733127
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
    Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
    Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Holographic optogenetic stimulation of patterned neuronal activity for vision restoration.
    Reutsky-Gefen I; Golan L; Farah N; Schejter A; Tsur L; Brosh I; Shoham S
    Nat Commun; 2013; 4():1509. PubMed ID: 23443537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.
    Jones MK; Lu B; Girman S; Wang S
    Prog Retin Eye Res; 2017 May; 58():1-27. PubMed ID: 28111323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Restoring vision in mice with retinal degeneration using multicharacteristic opsin.
    Wright W; Gajjeraman S; Batabyal S; Pradhan S; Bhattacharya S; Mahapatra V; Tripathy A; Mohanty S
    Neurophotonics; 2017 Oct; 4(4):041412. PubMed ID: 28840163
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic approaches for retinitis pigmentosa].
    Pach J; Gekeler F
    Klin Monbl Augenheilkd; 2013 May; 230(5):512-8. PubMed ID: 23695848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mapping retinal degeneration and loss-of-function in Rd-FTL mice.
    Greferath U; Goh HC; Chua PY; Astrand E; O'Brien EE; Fletcher EL; Murphy M
    Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5955-64. PubMed ID: 19661224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions of Prosthetic and Natural Vision in Animals With Local Retinal Degeneration.
    Lorach H; Lei X; Galambos L; Kamins T; Mathieson K; Dalal R; Huie P; Harris J; Palanker D
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7444-50. PubMed ID: 26618643
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optogenetic Approaches to Restoring Vision.
    Pan ZH; Lu Q; Bi A; Dizhoor AM; Abrams GW
    Annu Rev Vis Sci; 2015 Nov; 1():185-210. PubMed ID: 28532375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Challenges of cell therapies for retinal diseases.
    Christelle M; Lise M; Ben M'Barek K
    Int Rev Neurobiol; 2022; 166():49-77. PubMed ID: 36424096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.